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Inducible neuronal PrP knockout
• Tamoxifen-inducible neuronal 
Cre (NSECreER)
– Neuron specific enolase promoter
– Cre activity regulated by modified 
oestrogen receptor sensitive only 
to tamoxifen
• Gene-targeted loxP sites 
flanking PrP gene (PrPfl)
– Expresses PrP normally
– No expression following Cre-
mediated recombination
Prnp Exon 3
CreCre ERTxNSE
promoter Fusion protein
Characterization
Incubation period results
Neuropathology
Neuropathology
Cerebellum
Comparative Pathology
Neuropathology ME7 ME7 Neuronal PrP KO
Hippocampal neuronal loss
(pyramidal / granule cells)
  Rescue*
- MAP2 loss   disruption
- Synaptophysin loss   disruption
Vacuolation   Cornu ammonis
 Dentate gyrus
PrPSc deposition   Patchy§ (Cornu ammonis / cortex)
 Smooth / Neuropil (Dentate gyrus)
Reactive Astrocyte  
- GFAP+ /  cytoskeletal Hypermorphy   extreme§
Reactive Microglia   reduced
- Iba1 +  
- Infiltrate   rare around neurones
Cerebellum
Granule neurone loss
 minimal  Loss to extreme loss§
§Increasing with incubation period
Cerebellum
Purkinje cell loss
 minimal  Extreme to minimal (rescue)*
*reduced with increasing incubation period
Timed neuronal PrP knockout
Summary
• Induced knockout of neuronal PrP
– Extends incubation period
• Both prior to infection and at any point up until overt 
clinical phase of disease
– Alters pathology
• Involvement of astrocytes
• Removes correlation between hallmark pathologies
– White matter degeneration with aging
• In absence of disease
Conclusions
• Therapeutic PrP depletion strategies
– Target both neurones and astrocytes for 
maximal effect
– Avoid myelin degeneration phenotype
Further work
• Astrocytes
– Differential susceptibilities to disease
– Infection non-fatal to cell 
– Fundamental difference to neurones?
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